entertainment -WSS

entertainment

author：focus 2025-08-19 20:47:33 - browse：79

Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： U.K. sequencing study surfaces new findings about tumor DNA

explore

WSS

General Catalyst, Summa Health deal will turn on physician buy

Ahead of JPM, here's who's profiting most in health care

The lessons of Aduhelm, an Alzheimer's drug that was not to be

A single drug, study failures leave Anavex with nothing but cash

Time to name cancers by genetics, not organ of origin, expert says

General Catalyst, Summa Health deal will turn on physician buy

knowledge

entertainment

focus

Bright Health sells Medicare Advantage business to Molina

Quicker fix for pulse oximeters urged during FDA public meeting

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

New weight loss drugs work. But how can they best be used?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA drug safety: Singulair case shows systemic surveillance flaws

Drug repurposing or repositioning? The language matters

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Medicare proposal to cover medical devices draws a mixed reaction

Apple Vision Pro: A first look at health apps on the new VR headset

knowledge

New weight loss drugs work. But how can they best be used?

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Burning questions for the 2024 JPM Healthcare Conference

Goldman Sachs launches $650M fund for life science investments

Do digital therapeutics have a future in medicine?

Time to name cancers by genetics, not organ of origin, expert says

leisure time

knowledge

explore

knowledge